Diego Gomar Muñoz

• Planning and correct execution of the annual Evidence and Insights Generation Plan in collaboration with the RWE teams.
• Cocreation of the synthesis strategy for internal dissemination of HEOR-RWE results.
• Development of evidence generated value messages working in collaboration with medical affairs, market access, public affairs and marketing teams. Main focus on US market.
• Elaboration of pharmacoeconomic models to demonstrate the clinical and monetary value of our treatments to submit to health technology assessment agencies such as ICER. Main focus on US market.
• Development of value decks and digital tools to help the marketing, MAPA and medical affairs teams to present the value messages to both internal and external stakeholders.

Main achievements

• Economic model approved by ICER
• Development and launch of value message tool
• Participation on 3 RWE HEOR abstracts

• Elaboration and execution of access innovative strategies as well as added value proposals for the entire portfolio; coordinating access, medical, marketing and legal teams. Focus on Mexican market.
• Elaboration of full health economics dossiers for the company’s pipeline . Execution of the submission process of these dossiers, both to private or public decision-making institutions including presenting to key decision makers to achieve institutional access.
• Elaboration and publication of HEOR-RWE articles, posters and abstracts to fulfill gaps to strength our value messaging and economic dossiers.
• Design and implementation of real world evidence generation projects, coordinating efforts to achieve the best possible execution.
• Development of pricing strategies across both and public markets

Main achievements

• 3 listed molecules on the National Formulary
• 1 orphan drug listed on the National Formulary
• 2 RWE projects implemented

Main achievements

• 13 new listed molecules/indications on the National Formulary
• 9 molecules achieved full access across the Mexican public health system institutions (excluding IMSS Bienestar)
• 5 RWE publications achieved
• Development and launch of a patient access program